Michigan § 333.26452 Availability of investigational drug, biological product, or device.

Michigan Statutes

§ 333.26452 — Availability of investigational drug, biological product, or device.

Michigan § 333.26452

Ch. 333HEALTH

Act 345 of 2014RIGHT TO TRY ACT (333.26451-333.26457)

This text of Michigan § 333.26452 (Availability of investigational drug, biological product, or device.) is published on Counsel Stack Legal Research, covering Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mich. Comp. Laws § 333.26452 (2026).

Text

RIGHT TO TRY ACT (EXCERPT) Act 345 of 2014 333.26452 Availability of investigational drug, biological product, or device. Sec. 2.

(1)A manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request the manufacturer's investigational drug, biological product, or device under this act. This act does not require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient.

(2)A manufacturer may do all of the following:

(a)Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation.

(b)Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological pr

Free access — add to your briefcase to read the full text and ask questions with AI

RIGHT TO TRY ACT (EXCERPT) Act 345 of 2014 333.26452 Availability of investigational drug, biological product, or device. Sec. 2. (1) A manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request the manufacturer's investigational drug, biological product, or device under this act. This act does not require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient. (2) A manufacturer may do all of the following: (a) Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation. (b) Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.